THOUSANDS of patients are set to benefit from Hammersmith Hospital receiving nearly £11m in funding to develop new ground-breaking treatments.
Imperial College Healthcare NHS Trust received the hefty sum after their grant application to the National Institute for Health Research (NIHR) was approved after being judged by industry experts.
The cash will be used to support its newly-refurbished Wellcome Trust McMichael Clinical Research Facility which runs studies into treatments for conditions such as cancer, diabetes, stroke and obesity and will also pay for nurses and technicians.
Martin Wilkins, director of clinical investigative sciences at the trust, said: “This is a very prestigious award and is testament to the excellent clinical research already happening in Imperial College Healthcare NHS Trust.
“This funding, and the strong partnership between Imperial College London and our trust, will ensure we are well placed to translate the latest research discoveries into clinical practice to benefit our patients.”
The ten-year-old centre specialises in human trials and has 13-beds, four patient waiting rooms, two quarantine rooms, two sample processing labs and four consulting rooms and is currently working on 50 studies.
Karen Mosley, centre manager, said: “We can now offer the volunteers who take part in our trials top-flight facilities in a relaxing and modern environment.
“We are keen to welcome researchers from across our trust and Imperial College London to take advantage of the research our centre has to offer.”
In November 2010, Chronicle reporter Greg Burns put himself forward for a clinical trial at Hammersmith Hospital. Read his experience here .
